Cargando…
Application effect of phloroglucinol injection in elderly patients with spastic abdominal pain in emergency department
BACKGROUND: Although norepinephrine injection is commonly used in emergency situations, it is associated with risks for elderly patients with spasmodic liver pain. This study explores the safety and effectiveness of mebendazole injection, an alternative treatment option, for the emergency management...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10450372/ https://www.ncbi.nlm.nih.gov/pubmed/37637688 http://dx.doi.org/10.12998/wjcc.v11.i23.5440 |
_version_ | 1785095183762718720 |
---|---|
author | Liu, Yu-Fei Chen, Jian |
author_facet | Liu, Yu-Fei Chen, Jian |
author_sort | Liu, Yu-Fei |
collection | PubMed |
description | BACKGROUND: Although norepinephrine injection is commonly used in emergency situations, it is associated with risks for elderly patients with spasmodic liver pain. This study explores the safety and effectiveness of mebendazole injection, an alternative treatment option, for the emergency management of spasmodic abdominal pain, while minimizing adverse reactions, in elderly patients. AIM: To explore the development of norepinephrine injection and the adverse reactions of this drug in emergency elderly patients with spasmodic liver pain. METHODS: The control group consisted of 56 elderly patients visiting our hospital from January 2021 to December 2021. After hospital admission, the control group was intravenously administered tolopin. The experimental group consisted of 56 emergency patients with spasmodic abdominal pain who visited our hospital until June 2022. After hospital admission, the experimental group was intravenously administered toloxazole. The two groups were treated for 3 d. The disappearance of clinical symptoms was observed before and after the treatment, and the difference in adverse reactions between the two groups was compared. RESULTS: The pain of the wife, fire, diarrhea, drowning, and surrounding time disappeared in the experimental group. No statistical difference was observed between the experimental and control groups in visual pain analog scale (VAS) scores before and after the treatment (P > 0.05). The VAS scores of abdominal pain severity after 0.5 h, 1.0 h, and after 6.0 h of treatment were significantly lower for the experimental group than for the control group. After the treatment, the therapeutic effect in the experimental group was higher and statistically significant than that in the control group (P < 0.05). The probability of adverse reactions before the treatment was lower in the experimental group than in the control group. CONCLUSION: During emergency, mebendazole injection exhibited a good therapeutic value when used for the clinical treatment of elderly patients with spasmodic stomach pain. It accelerated the disappearance of clinical symptoms such as stomach pain, reduced the stomach weight, and improved clinical activity. Reducing and promoting the frequency of high treatment safety with mebendazole injection is worthwhile. |
format | Online Article Text |
id | pubmed-10450372 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-104503722023-08-26 Application effect of phloroglucinol injection in elderly patients with spastic abdominal pain in emergency department Liu, Yu-Fei Chen, Jian World J Clin Cases Retrospective Study BACKGROUND: Although norepinephrine injection is commonly used in emergency situations, it is associated with risks for elderly patients with spasmodic liver pain. This study explores the safety and effectiveness of mebendazole injection, an alternative treatment option, for the emergency management of spasmodic abdominal pain, while minimizing adverse reactions, in elderly patients. AIM: To explore the development of norepinephrine injection and the adverse reactions of this drug in emergency elderly patients with spasmodic liver pain. METHODS: The control group consisted of 56 elderly patients visiting our hospital from January 2021 to December 2021. After hospital admission, the control group was intravenously administered tolopin. The experimental group consisted of 56 emergency patients with spasmodic abdominal pain who visited our hospital until June 2022. After hospital admission, the experimental group was intravenously administered toloxazole. The two groups were treated for 3 d. The disappearance of clinical symptoms was observed before and after the treatment, and the difference in adverse reactions between the two groups was compared. RESULTS: The pain of the wife, fire, diarrhea, drowning, and surrounding time disappeared in the experimental group. No statistical difference was observed between the experimental and control groups in visual pain analog scale (VAS) scores before and after the treatment (P > 0.05). The VAS scores of abdominal pain severity after 0.5 h, 1.0 h, and after 6.0 h of treatment were significantly lower for the experimental group than for the control group. After the treatment, the therapeutic effect in the experimental group was higher and statistically significant than that in the control group (P < 0.05). The probability of adverse reactions before the treatment was lower in the experimental group than in the control group. CONCLUSION: During emergency, mebendazole injection exhibited a good therapeutic value when used for the clinical treatment of elderly patients with spasmodic stomach pain. It accelerated the disappearance of clinical symptoms such as stomach pain, reduced the stomach weight, and improved clinical activity. Reducing and promoting the frequency of high treatment safety with mebendazole injection is worthwhile. Baishideng Publishing Group Inc 2023-08-16 2023-08-16 /pmc/articles/PMC10450372/ /pubmed/37637688 http://dx.doi.org/10.12998/wjcc.v11.i23.5440 Text en ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. |
spellingShingle | Retrospective Study Liu, Yu-Fei Chen, Jian Application effect of phloroglucinol injection in elderly patients with spastic abdominal pain in emergency department |
title | Application effect of phloroglucinol injection in elderly patients with spastic abdominal pain in emergency department |
title_full | Application effect of phloroglucinol injection in elderly patients with spastic abdominal pain in emergency department |
title_fullStr | Application effect of phloroglucinol injection in elderly patients with spastic abdominal pain in emergency department |
title_full_unstemmed | Application effect of phloroglucinol injection in elderly patients with spastic abdominal pain in emergency department |
title_short | Application effect of phloroglucinol injection in elderly patients with spastic abdominal pain in emergency department |
title_sort | application effect of phloroglucinol injection in elderly patients with spastic abdominal pain in emergency department |
topic | Retrospective Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10450372/ https://www.ncbi.nlm.nih.gov/pubmed/37637688 http://dx.doi.org/10.12998/wjcc.v11.i23.5440 |
work_keys_str_mv | AT liuyufei applicationeffectofphloroglucinolinjectioninelderlypatientswithspasticabdominalpaininemergencydepartment AT chenjian applicationeffectofphloroglucinolinjectioninelderlypatientswithspasticabdominalpaininemergencydepartment |